News for Healthier Living
Patients with Unexplainable Chronic Itch Have Unique Blood Biomarkers that Could Eventually Lead to New Targeted Treatments
Millions of patients worldwide suffer from a chronic itching condition with no identifiable cause - a condition known as chronic pruritus of unknown origin (CPUO) - that has no targeted therapies approved to treat it. Many of these patients suffer for years with little relief, but a new University of Maryland School of Medicine study may provide hope for future treatments. Patients were found to have lower than normal levels of metabolite biomarkers in the blood plasma that could point to a cause of their excruciating symptoms.
August 14, 2024
September 10 2024September 9 2024September 8 2024September 7 2024September 6 2024September 5 2024September 4 2024September 3 2024September 2 2024September 1 2024August 31 2024August 30 2024August 29 2024August 28 2024
|
|
|
|
|